Portfolio write-downs signal valuation issues: Management recorded material impairments on Planters and Chi-Chi's brands in Q4 FY2025, following previous Justin's write-down in FY2023, revealing a pattern of overpaying for acquisitions and systemic challenges in maintaining brand value across key assets Strategic retreat through accelerated divestitures: Three business exits within two months…

Our analysis rates this filing BEARISH. The HIGH concern level (7.8/10) reflects a company experiencing significant strategic and operational challenges. The simultaneous impairment of two major indefinite-lived intangible assets (Planters and Chi-Chi's) in Q4 FY2025 is highly unusual and signals…

Concern level: HIGH (7.8/10). Key factors: Multiple brand impairments in single quarter (Planters and Chi-Chi's) indicating systematic overvaluation of intangible assets; Three business exits within short timeframe (Hormel Health Labs, Mountain Prairie sold; Justin's held for sale) signals forced portfolio rationalization; Escalating pattern of impairments: Justin's in FY2023, now Planters and…

Notable risk changes: Major brand impairments: Planters and Chi-Chi's trade names written down in Q4 FY2025, signaling significant deterioration in brand value and cash flow expectations for key portfolio assets; Accelerated portfolio rationalization: Three business exits (Hormel Health Labs sold Oct 2024, Mountain Prairie sold Nov 2024, Justin's held for sale with expected Q1 FY2026 close) indicates strategic…

The model predicts HRL will underperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.